Search

Displaying results 6251 - 6260 of 10000 in total
  1. Drug

    Surzetoclax

    go.drugbank.com/drugs/DB21698
    Investigational

    Surzetoclax has a monoisotopic molecular weight of 1038.41 Da. … Surzetoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  2. Drug

    Bardoxolone methyl

    go.drugbank.com/drugs/DB05983
    Investigational

  3. Drug

    Bradanicline

    go.drugbank.com/drugs/DB06090
    Investigational

    Bradanicline belongs to a new class of drugs for the treatment of central nervous system diseases and disorders. … Bradanicline, a novel small molecule that modulates the activity of the neuronal nicotinic receptor (NNR) subtype known as alpha7(α7).

  4. Drug

    PF-08046040

    go.drugbank.com/drugs/DB17555
    Investigational

    SEA-CD70 is an investigational humanized, non-fucosylated monoclonal antibody targeting CD70. … SEA-CD70 is under investigation in clinical trial NCT04227847 (A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies).

  5. Drug

    Cabiotraxetan

    go.drugbank.com/drugs/DB20465
    Experimental

    Cabiotraxetan has a monoisotopic molecular weight of 714.41 Da. … Cabiotraxetan is a small molecule drug. The usage of the INN stem '-xetan' in the name indicates that Cabiotraxetan is a chelating agent.

  6. Drug

    Cligosiban

    go.drugbank.com/drugs/DB20573
    Experimental

    Cligosiban is a small molecule drug. The usage of the INN stem '-siban' in the name indicates that Cligosiban is a oxytocin antagonist. Cligosiban has a monoisotopic molecular weight of 419.12 Da.

  7. Drug

    Dutacatib

    go.drugbank.com/drugs/DB20890
    Experimental

    Dutacatib is a small molecule drug. The usage of the INN stem '-catib' in the name indicates that Dutacatib is a cathepsin inhibitor. Dutacatib has a monoisotopic molecular weight of 421.26 Da.

  8. Drug

    EGEN-001

    go.drugbank.com/drugs/DB05953
    Investigational

    EGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12) and a biocompatible, biodegradable delivery polymer with potential antineoplastic activity

  9. Drug

    Amediplase

    go.drugbank.com/drugs/DB06679
    Experimental

    Amediplase is a recombinant chimeric plasminogen activator, consisting of the kringle 2 domain from the A-chain of tissue plasminogen activator (t-PA) and the carboxy terminal region of pro-urokinase.

  10. Drug

    Sitamaquine

    go.drugbank.com/drugs/DB04909
    Investigational

    Sitamaquine (WR-6026) is an orally active 8-aminoquinoline analog in development by the Walter Reed Army Institute, in collaboration with GlaxoSmithKline (formerly SmithKline Beecham), for the potential